首页|OTOF基因相关听神经病致病机制及基因治疗的研究进展

OTOF基因相关听神经病致病机制及基因治疗的研究进展

Research Progress on the Pathogenesis and Gene Therapy of OTOF Mutation-Associ-ated Auditory Neuropathy

扫码查看
听神经病(auditory neuropathy,AN)是一种由内毛细胞、听神经突触或听神经本身的功能障碍引起听力损失的疾病,占儿童永久性听力障碍的7%~10%.现有研究表明,遗传因素是听神经病的主要致病因素.目前,明确与AN相关的基因有很多,其中OTOF基因是第一个被发现且致病机制研究较为清楚的基因.OTOF基因相关AN的基因治疗研究已在动物模型中开展,并有望应用于AN的临床治疗.我们将从AN的致病机制、听力学临床表型及治疗进展等方面对OToF基因相关AN进行文献回顾和研究展望.
Auditory neuropathy(AN)is a disorder in which hearing loss is caused by dysfunction of the inner hair cells,the synapses of the auditory nerve,or the auditory nerve itself,accounting for 7%~10%of permanent hearing impairment in children.Existing studies suggest that genetic factors are the main causative factors in auditory neuropa-thy.There are many genes clearly associated with AN,among which the OTOF gene is the first gene identified and its pathogenic mechanism is relatively well studied.Gene therapy associated with the OTOF gene has been studied in ani-mal models and is expected to be applied to the treatment of auditory neuropathy in the near future.In this paper,we will review the literature and provide an outlook on OTOF mutation-related auditory neuropathies in terms of pathogenesis,audiological and clinical phenotype,and therapeutic advances.

auditory neuropathyOTOF geneOtoferlincochlear implantsgene therapy

柴静、边盼盼、徐百成、郭玉芬

展开 >

兰州大学第二医院耳鼻咽喉头颈外科(兰州 730030)

听神经病 OTOF基因 Otoferlin蛋白 人工耳蜗植入 基因治疗

国家自然科学基金国家自然科学基金国家自然科学基金甘肃省健康产业规划项目甘肃省健康产业规划项目兰州大学第二医院技术创新项目

31960132815709263216014920JR10RA74721JR7RA429CY2019-QN18

2024

中华耳科学杂志
解放军总医院耳鼻咽喉科研究所

中华耳科学杂志

CSTPCD北大核心
影响因子:0.954
ISSN:1672-2922
年,卷(期):2024.22(2)